GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » ROCE %

Paxman AB (FRA:B0F) ROCE % : 14.49% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Paxman AB's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.49%.


Paxman AB ROCE % Historical Data

The historical data trend for Paxman AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB ROCE % Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -3.68 -33.45 -13.16 -0.93 9.99

Paxman AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.85 -5.55 5.19 25.69 14.49

Paxman AB ROCE % Calculation

Paxman AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1.129/( ( (15.824 - 4.917) + (14.94 - 3.25) )/ 2 )
=1.129/( (10.907+11.69)/ 2 )
=1.129/11.2985
=9.99 %

Paxman AB's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=1.636/( ( (15.361 - 4.47) + (14.94 - 3.25) )/ 2 )
=1.636/( ( 10.891 + 11.69 )/ 2 )
=1.636/11.2905
=14.49 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paxman AB  (FRA:B0F) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Paxman AB ROCE % Related Terms

Thank you for viewing the detailed overview of Paxman AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB (FRA:B0F) Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines